Publication:
Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey

Simple item page
dc.contributor.authorYUMUK, PERRAN FULDEN
dc.contributor.authorsKilickap, S.; Demirci, U.; Bugdayci, F.; Tural, D.; Korkmaz, T.; Paydas, S.; Yilmaz, C.; Turna, H.; Sezer, A.; Cinkir, H. Yesil; Okutur, K.; Erman, M.; Eralp, Y.; Cabuk, D.; Isikdogan, A.; Demirkazik, A.; Karaoglu, A.; Yazilitas, D.; Senler, F. Cay; Yumuk, P. F.; Coskun, H.; Yildiz, I.; Oztop, I.; Beypinar, I.; Aydin, K.; Kaplan, M.; Meydan, N.; Olmez, O. F.; Ozyilkan, O.; Seber, S.; Arslan, C.; Sendur, M. A.; Cicin, I.
dc.date.accessioned2022-03-14T15:18:25Z
dc.date.accessioned2026-01-10T20:36:17Z
dc.date.available2022-03-14T15:18:25Z
dc.date.issued2019-10
dc.identifier.doi10.1016/j.jtho.2019.08.1166
dc.identifier.eissn1556-1380
dc.identifier.issn1556-0864
dc.identifier.urihttps://hdl.handle.net/11424/246077
dc.identifier.wosWOS:000492162203082
dc.language.isoeng
dc.publisherELSEVIER SCIENCE INC
dc.relation.ispartofJOURNAL OF THORACIC ONCOLOGY
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectALK positive
dc.subjectROS1 positive
dc.subjectLorlatinib
dc.subjectAdvanced stage lung cancer
dc.titleLorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPageS559
oaire.citation.issue10
oaire.citation.startPageS558
oaire.citation.titleJOURNAL OF THORACIC ONCOLOGY
oaire.citation.volume14

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
file.pdf
Size:
419.92 KB
Format:
Adobe Portable Document Format
Download

Collections

Araştırma Çıktıları